Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 9:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2833–2856 of 4,075 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-study Clear all

Conditions: Diabetes Mellitus, Type 2
Interventions: Insulin icodec, Placebo (insulin 287), Metformin, Dipeptidyl peptidase-4 inhibitors, Insulin glargine, Placebo (insulin glargine); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 247 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 14
States / cities: Lancaster, California • Ventura, California • Walnut Creek, California + 9 more

Conditions: Huntington Disease
Interventions: Time-Restricted Eating Diet; Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Heart Failure, Systolic, Depression, Cardiovascular Disease
Interventions: Collaborative Care for Heart Failure, Collaborative Care for Depression; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years and older
Enrollment: 756 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma, Malignant Solid Neoplasm, Prostate Carcinoma
Interventions: Educational Intervention, Electronic Health Record Review, Follow-Up, Internet-Based Intervention, Interview, Survey Administration; Other · Procedure
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Generalized Anxiety Disorder
Interventions: Empower Neuromodulation System; Device
Lead sponsor: Theranova, L.L.C.; Industry
Eligibility: 19 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Asthma
Interventions: Technology Enabled Asthma Management System; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Vaginal Infection, Vaginal Discharge, Vaginosis, Sexual Dysfunction
Interventions: LiviWell Postcoital Vaginal Insert; Device
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Mountain Lakes, New Jersey

Conditions: Dry Eye
Interventions: HL036 Ophthalmic Solution, Placebo; Biological
Lead sponsor: HanAll BioPharma Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 12
States / cities: Phoenix, Arizona • Newport Beach, California • Torrance, California + 9 more

Conditions: Smoking, Tobacco Use, Electronic Cigarette Use
Interventions: P1211216, P1213416, P1213716, P1213616, P1213816, P1211916, P1210016, P1211217, P1213417, P1211222, P1213422, P1213722, P1213622, P1213822, P1211922, P1210022; Other
Lead sponsor: RAI Services Company; Industry
Eligibility: 21 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 4
States / cities: Stockbridge, Georgia • Lexington, Kentucky • Hickory, North Carolina + 1 more

Conditions: Skin Carcinoma
Interventions: Computer-Assisted Intervention, Dermatoscope, Educational Intervention, Educational Intervention (Physician), Questionnaire Administration, Text Message; Other · Device
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 840 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Duarte, California

Conditions: Neurodevelopmental Disorders
Interventions: Dance; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 8 Years to 12 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Integrated Care; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Type 1 Diabetes, Hypoglycemia
Interventions: Basic Education, Hypoglycemia Symptom Detection Training, Education Plus; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Tinnitus, Notched Noise Therapy
Interventions: Hearing Aid and Notched Noise Therapy, Hearing Aid and Broadband Noise, Hearing Aid; Combination Product · Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: High Blood Pressure
Interventions: Self-Help Intervention Program-High Blood Pressure; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years to 65 Years
Enrollment: 445 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Ellicott City, Maryland

Conditions: Cardiovascular Diseases, Lifestyle Factors
Interventions: Generic text messages, Interactive AI chatbot text messaging, Proactive pharmacist support; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 89 Years
Enrollment: 2,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Denver, Colorado • Fort Lupton, Colorado • Wheat Ridge, Colorado

Conditions: Chronic Pain, Chiari Malformation
Interventions: Online Acceptance and Commitment Therapy Intervention + Phone Coaching, Online Acceptance and Commitment Therapy Intervention without phone coaching; Behavioral
Lead sponsor: Kent State University; Other
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Kent, Ohio

Conditions: Parenting
Interventions: Video Interaction Project (VIP) program; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 1 Day and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Colorectal Cancer, Colorectal Adenocarcinoma
Interventions: Brivanib, Irinotecan; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Reading
Interventions: Sit Together and Read (STAR); Behavioral
Lead sponsor: Sherine Tambyraja; Other
Eligibility: 4 Years to 6 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Dublin, Ohio

Conditions: Prostate Carcinoma
Interventions: Biospecimen Collection, Dietary Intervention, Fasting; Procedure · Other · Behavioral
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Diabetes Mellitus, Type 2
Interventions: Brief CBT; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 30 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Eating Disorders
Interventions: Family Based Treatment-Primary Care, Family-Based Treatment; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 7 Years to 18 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Anus Neoplasms
Interventions: Self-anal exam arm; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 27 Years to 80 Years · Male only
Enrollment: 201 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Time-Restricted Eating in Huntington's Disease: A Clinical Pilot Study

Blended Collaborative Care for Heart Failure and Co-Morbid Depression

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

Empower Neuromodulation System - Pilot Study for Anxiety Treatment

Technology Enabled Asthma Management System (TEAMS) Pilot Study

Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters

A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes

CSD201203: A Study to Determine Subject Puffing Patterns of a Non-cylindrical, Closed, Electronic Nicotine Delivery System at Three Nicotine Concentrations in an Ambulatory Setting

Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study

Dance for Children With Autism

Integrated Care Program for Chronic Obstructive Pulmonary Disease

Pilot Feasibility Study for HypoPals, a Mobile Health Program for Improving Hypoglycemia Management.

Notched Noise Therapy for Suppression of Tinnitus

Intervention Study to Control High Blood Pressure for Korean American

Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors

Examining Different Components of Online Acceptance and Commitment Therapy for People With Chiari Malformation

Video Interaction Project in Brazil

Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF

Sit Together and Read (STAR): A Pilot Study of Children and Their Kinship Caregivers

Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance

Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot Study

A Study to Evaluate Primary Care Treatment for Adolescent Eating Disorders

The Feasibility of Self or Partner-assisted Digital Anal Exam Screening